Similar articles

• Possible role of nerve growth factor and interleukin-18 in pathogenesis of eczematous lesions of atopic dermatitis.

  Shaker OG, El-Komy M, Tawfic SO, Zeidan N, Tomairek RH. Shaker OG, et al. J Dermatol Sci. 2009 Feb;53(2):153-4. doi: 10.1016/j.jdermsci.2008.08.018. Epub 2008 Oct 15. J Dermatol Sci. 2009. PMID: 18922682 No abstract available.
• Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

  Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, Luger TA, Muraro A, Novak N, Platts-Mills TA, Rosenwasser L, Scheynius A, Simons FE, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T; European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology. Akdis CA, et al. J Allergy Clin Immunol. 2006 Jul;118(1):152-69. doi: 10.1016/j.jaci.2006.03.045. J Allergy Clin Immunol. 2006. PMID: 16815151 Review.
• Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis.

  Taha RA, Minshall EM, Leung DY, Boguniewicz M, Luster A, Muro S, Toda M, Hamid QA. Taha RA, et al. J Allergy Clin Immunol. 2000 May;105(5):1002-7. doi: 10.1067/mai.2000.106483. J Allergy Clin Immunol. 2000. PMID: 10808183
• Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis.

  Tazawa T, Sugiura H, Sugiura Y, Uehara M. Tazawa T, et al. Arch Dermatol Res. 2004 Apr;295(11):459-64. doi: 10.1007/s00403-004-0455-6. Epub 2004 Mar 10. Arch Dermatol Res. 2004. PMID: 15014952
• [Etiology and treatment of atopic dermatitis in the light of new data].

  Gendek H. Gendek H. Pol Tyg Lek. 1981 Sep 14;36(37):1447-50. Pol Tyg Lek. 1981. PMID: 6278456 Review. Polish. No abstract available.